orka-002
orka-002: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Phase 1 |
Clinical Trials (1)
A Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Dose-Range Finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Participants With Moderate-to-Severe Plaque Psoriasis
Frequently asked questions
Who is developing orka-002?
orka-002 is being developed by Oruka Therapeutics, Inc..
How many clinical trials involve orka-002?
BioSniper tracks 1 clinical trial involving orka-002.
Get deeper analysis on orka-002
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis